Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are female
- People aged 45 or older
- People diagnosed with a specific type of early-stage breast cancer — either invasive breast cancer up to 3.5 cm in size that is estrogen-receptor positive and has not spread to nearby lymph nodes, or a non-invasive type called DCIS that is low-to-moderate grade, under 2.5 cm, estrogen-receptor positive, and found on a mammogram
- People for whom breast-conserving surgery (removing only the tumour, not the whole breast) is considered appropriate by their doctor
- People who have no medical reasons preventing them from receiving radiation therapy
- People who have had a mammogram within the 6 months before the planned procedure
- People considered healthy enough to undergo a lumpectomy under general anaesthetic
- People whose treatment plan includes a type of radiation given during surgery (called IORT — intraoperative radiation therapy)
Who may not be able to join:
- People whose breast cancer is known to have spread to the lymph nodes under the arm
- People whose cancer is found in more than one area of the same breast, where a single lumpectomy would not be able to remove all of it with clear margins
- People known to carry a BRCA1 or BRCA2 gene mutation (inherited gene changes linked to breast cancer risk)
- People who are receiving chemotherapy before surgery (neoadjuvant chemotherapy)
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jana Fox, MD, Montefiore Medical Center
Phone: 718-920-4140
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of patients with locally controlled disease; Number of patients with regionally controlled disease; Number of patients with grade 2 or higher toxicities
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.